Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication. | ||||||||
|
Biomarkers for Alzheimer's disease.Ward M Proteome Sciences plc, South Wing Laboratory (PO 045), Institute of Psychiatry, London, SE5 8AF, UK. malcolm.ward@proteomics.com Alzheimer's disease (AD) is a horribly debilitating disease that will increase in prevalence as the populations of the USA and Europe continue to age. It is expected that the USA alone will see some 16 million cases by 2050. At present, there is no cure for the disease and early diagnosis is all but impossible. The onset of disease is not manifested clinically and little is known regarding the cause of nonfamiliar AD. There is a need for biomarkers associated with AD to aid the diagnosis of this disease and to detect progression. Especially needed are biomarkers to monitor the effect of new drugs and therapeutic strategies as they are developed. A biomarker may be a genetic trait, a biochemical change, such as a protein, peptide or metabolite, or a change in a structural or functional feature detected using imaging technology. This review aims to cover the important field of biomarker research in association with AD. Published 25 September 2007 in Expert Rev Mol Diagn, 7(5): 635-46.
© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved. |
| ||||||
